TNF biology, pathogenic mechanisms and emerging therapeutic strategies
By G. Kalliolias, L. Ivashkiv. Nature Reviews Rheumatology, 2015
1,274 citations recorded by the source corpus.
TNF is a pleiotropic cytokine with important functions in homeostasis and disease pathogenesis. Recent discoveries have provided insights into TNF biology that introduce new concepts for the development of therapeutics for TNF-mediated diseases. The model of TNF receptor signalling has been extended to include linear ubiquitination and the formation of distinct signalling complexes that are linked with different functional outcomes, such as inflammation, apoptosis and necroptosis. Our understanding of TNF-induced gene expression has been enriched by the discovery of epigenetic mechanisms and concepts related to cellular priming, tolerization and induction of 'short-term transcriptional memory'. Identification of distinct homeostatic or pathogenic TNF-induced signalling pathways has introduced the concept of selectively inhibiting the deleterious effects of TNF while preserving its homeostatic bioactivities for therapeutic purposes. In this Review, we present molecular mechanisms underlying the roles of TNF in homeostasis and inflammatory disease pathogenesis, and discuss novel strategies to advance therapeutic paradigms for the treatment of TNF-mediated diseases.
Subfields: Cancer Research, Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/052175d18abbb82522ccfba46c57c1f720b20ae1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Hye-Yoon Shin
- Jong-Hwi Park
- Dan-in Jang
- Sang-Ryong Lee
- Seung-Hoon Yang
- Hyo-Ryeong Song
- D. Sharma
- T. Kang
Citations in the corpus
- Necroptosis: a regulated inflammatory mode of cell death (2018, background): “iasis, bowel disease, and rheumatoid arthritis [19, 20] and regulates production of chemokines and cytokines as primary outcomes of TNF stimulation [21].”
- The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics (2021, background): “Unlike complex I, which is assembled at the plasma membrane, complexes IIa, IIb, and IIc are assembled in the cytoplasm [17].”